Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms.
about
The latent transforming growth factor beta binding protein (LTBP) familyAutocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferationStem cell pathways contribute to clinical chemoresistance in ovarian cancerLatent transforming growth factor β-binding protein 4 is downregulated in esophageal cancer via promoter methylation.Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functionsEndoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy statusExpression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralizationEndoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancerSphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.Current status of bevacizumab in advanced ovarian cancermicroRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition.TGFβ Controls Ovarian Cancer Cell ProliferationLTBP3 promotes early metastatic events during cancer cell dissemination.Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma.M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine.
P2860
Q24532213-0C5CAF31-770A-40FC-80FD-AEB57F89D4E6Q24629138-2BD80152-AA53-4D37-94D8-F9A0E034A321Q34092005-4CFE57ED-A5E4-48F1-9A42-E434815C6D2DQ34761409-B3F7AA93-89B8-44BB-BCC6-0248C67DD4D1Q34856178-2B288D15-ADB7-4327-9B3B-2F25A971F0B9Q34978084-E5F66B7B-E3DF-4BBD-8E3A-7372CCCE66BFQ35003102-C00702D5-368C-449A-87A6-891DE068C927Q35081677-3AC7E422-BB7C-4717-88BF-B5C763329657Q35753569-9B81B965-D5C2-4AFE-8CC0-9054D0DB7EA3Q36510958-59206098-7D35-490E-AA81-889C09350571Q36782379-0E512324-408B-4F2A-BEE6-F198663B3DEEQ37048186-0A669890-5479-4288-8806-7824E18432DEQ37497239-7191041D-0817-4BEC-A78E-16E865232998Q41573289-B61D6231-09E8-483A-AC38-8503D1C5B8BFQ49952435-6083843C-C53C-4BE3-8AA7-E48F9D5FAA64Q52896557-93303EA2-C82B-40E4-8596-964A16994762Q55037666-AE25D436-BF20-40D4-8471-BE874EF1DD97Q55184907-B7454457-782D-4C8E-A268-A0EDBBF45D94
P2860
Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Expression and prognostic sign ...... l ovary and ovarian neoplasms.
@en
Expression and prognostic sign ...... l ovary and ovarian neoplasms.
@nl
type
label
Expression and prognostic sign ...... l ovary and ovarian neoplasms.
@en
Expression and prognostic sign ...... l ovary and ovarian neoplasms.
@nl
prefLabel
Expression and prognostic sign ...... l ovary and ovarian neoplasms.
@en
Expression and prognostic sign ...... l ovary and ovarian neoplasms.
@nl
P2093
P1476
Expression and prognostic sign ...... l ovary and ovarian neoplasms.
@en
P2093
P304
P577
1995-08-01T00:00:00Z